These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 28587082)
1. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M Molecules; 2017 May; 22(6):. PubMed ID: 28587082 [TBL] [Abstract][Full Text] [Related]
2. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
3. Marine Natural Products as Models to Circumvent Multidrug Resistance. Long S; Sousa E; Kijjoa A; Pinto MM Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665 [TBL] [Abstract][Full Text] [Related]
4. Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells. Stark M; Assaraf YG Oncotarget; 2017 Jul; 8(30):49973-49987. PubMed ID: 28637003 [TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
6. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901 [TBL] [Abstract][Full Text] [Related]
7. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976 [TBL] [Abstract][Full Text] [Related]
8. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance. Karthikeyan S; Hoti SL Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696 [TBL] [Abstract][Full Text] [Related]
9. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR). Teodori E; Dei S; Martelli C; Scapecchi S Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921 [TBL] [Abstract][Full Text] [Related]
10. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1). Schmitt SM; Stefan K; Wiese M Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):69-79. PubMed ID: 27810353 [TBL] [Abstract][Full Text] [Related]
11. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558 [TBL] [Abstract][Full Text] [Related]
12. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer. Joshi P; Vishwakarma RA; Bharate SB Eur J Med Chem; 2017 Sep; 138():273-292. PubMed ID: 28675836 [TBL] [Abstract][Full Text] [Related]
14. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition. Dinić J; Podolski-Renić A; Jeremić M; Pešić M Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
17. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells. Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500 [TBL] [Abstract][Full Text] [Related]
18. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. Bansal T; Jaggi M; Khar RK; Talegaonkar S J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292 [TBL] [Abstract][Full Text] [Related]
19. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein. Erić S; Kalinić M; Ilić K; Zloh M SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents. Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]